Logo image of OLPX

OLAPLEX HOLDINGS INC (OLPX) Stock Fundamental Analysis

NASDAQ:OLPX - Nasdaq - US6793691089 - Common Stock - Currency: USD

1.38  -0.07 (-4.83%)

Premarket: 1.36 -0.02 (-1.45%)

Fundamental Rating

6

Overall OLPX gets a fundamental rating of 6 out of 10. We evaluated OLPX against 37 industry peers in the Personal Care Products industry. While OLPX has a great profitability rating, there are some minor concerns on its financial health. OLPX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make OLPX a good candidate for value investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

OLPX had positive earnings in the past year.
In the past year OLPX had a positive cash flow from operations.
Each year in the past 5 years OLPX has been profitable.
Each year in the past 5 years OLPX had a positive operating cash flow.
OLPX Yearly Net Income VS EBIT VS OCF VS FCFOLPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 100M 200M 300M

1.2 Ratios

The Return On Assets of OLPX (2.41%) is comparable to the rest of the industry.
The Return On Equity of OLPX (4.82%) is better than 63.89% of its industry peers.
OLPX's Return On Invested Capital of 3.95% is in line compared to the rest of the industry. OLPX outperforms 50.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OLPX is in line with the industry average of 13.48%.
The last Return On Invested Capital (3.95%) for OLPX is well below the 3 year average (14.05%), which needs to be investigated, but indicates that OLPX had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.41%
ROE 4.82%
ROIC 3.95%
ROA(3y)10.69%
ROA(5y)50.35%
ROE(3y)26.89%
ROE(5y)83.81%
ROIC(3y)14.05%
ROIC(5y)95.91%
OLPX Yearly ROA, ROE, ROICOLPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 100 200 300 400

1.3 Margins

OLPX has a better Profit Margin (9.78%) than 80.56% of its industry peers.
In the last couple of years the Profit Margin of OLPX has remained more or less at the same level.
OLPX has a better Operating Margin (19.38%) than 88.89% of its industry peers.
OLPX's Operating Margin has declined in the last couple of years.
OLPX's Gross Margin of 70.40% is fine compared to the rest of the industry. OLPX outperforms 63.89% of its industry peers.
In the last couple of years the Gross Margin of OLPX has grown nicely.
Industry RankSector Rank
OM 19.38%
PM (TTM) 9.78%
GM 70.4%
OM growth 3Y-13.39%
OM growth 5YN/A
PM growth 3Y-1.17%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5YN/A
OLPX Yearly Profit, Operating, Gross MarginsOLPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so OLPX is still creating some value.
OLPX has more shares outstanding than it did 1 year ago.
The debt/assets ratio for OLPX has been reduced compared to a year ago.
OLPX Yearly Shares OutstandingOLPX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 200M 400M 600M
OLPX Yearly Total Debt VS Total AssetsOLPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

OLPX has an Altman-Z score of 1.89. This is not the best score and indicates that OLPX is in the grey zone with still only limited risk for bankruptcy at the moment.
OLPX has a worse Altman-Z score (1.89) than 61.11% of its industry peers.
OLPX has a debt to FCF ratio of 4.71. This is a neutral value as OLPX would need 4.71 years to pay back of all of its debts.
The Debt to FCF ratio of OLPX (4.71) is better than 66.67% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that OLPX is somewhat dependend on debt financing.
OLPX's Debt to Equity ratio of 0.73 is on the low side compared to the rest of the industry. OLPX is outperformed by 69.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 4.71
Altman-Z 1.89
ROIC/WACC0.48
WACC8.22%
OLPX Yearly LT Debt VS Equity VS FCFOLPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.3 Liquidity

OLPX has a Current Ratio of 11.84. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
OLPX has a better Current ratio (11.84) than 100.00% of its industry peers.
A Quick Ratio of 10.32 indicates that OLPX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 10.32, OLPX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 11.84
Quick Ratio 10.32
OLPX Yearly Current Assets VS Current LiabilitesOLPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

OLPX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.00%.
Measured over the past years, OLPX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.85% on average per year.
The Revenue has decreased by -9.15% in the past year.
The Revenue has been growing by 17.53% on average over the past years. This is quite good.
EPS 1Y (TTM)-35%
EPS 3Y14.85%
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y17.53%
Revenue growth 5YN/A
Sales Q2Q%-3.62%

3.2 Future

OLPX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.80% yearly.
Based on estimates for the next years, OLPX will show a very strong growth in Revenue. The Revenue will grow by 20.75% on average per year.
EPS Next Y-31.79%
EPS Next 2Y-15.39%
EPS Next 3Y-15.69%
EPS Next 5Y-2.8%
Revenue Next Year-10.02%
Revenue Next 2Y-6.26%
Revenue Next 3Y-3.4%
Revenue Next 5Y20.75%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
OLPX Yearly Revenue VS EstimatesOLPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
OLPX Yearly EPS VS EstimatesOLPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.1 0.2 0.3 0.4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.62, which indicates a very decent valuation of OLPX.
OLPX's Price/Earnings ratio is rather cheap when compared to the industry. OLPX is cheaper than 88.89% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.75, OLPX is valued rather cheaply.
A Price/Forward Earnings ratio of 12.05 indicates a correct valuation of OLPX.
83.33% of the companies in the same industry are more expensive than OLPX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.44. OLPX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 10.62
Fwd PE 12.05
OLPX Price Earnings VS Forward Price EarningsOLPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OLPX is valued cheaper than 80.56% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, OLPX is valued cheaply inside the industry as 94.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.61
EV/EBITDA 7.5
OLPX Per share dataOLPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

The decent profitability rating of OLPX may justify a higher PE ratio.
OLPX's earnings are expected to decrease with -15.69% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.39%
EPS Next 3Y-15.69%

More info and screens

0

5. Dividend

5.1 Amount

OLPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OLAPLEX HOLDINGS INC

NASDAQ:OLPX (3/3/2025, 8:00:02 PM)

Premarket: 1.36 -0.02 (-1.45%)

1.38

-0.07 (-4.83%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)03-04 2025-03-04/bmo
Inst Owners14.56%
Inst Owner Change0.74%
Ins Owners1.62%
Ins Owner Change-3.58%
Market Cap914.83M
Analysts52
Price Target2.16 (56.52%)
Short Float %10.01%
Short Ratio10.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.67%
Min EPS beat(2)-9.37%
Max EPS beat(2)-1.96%
EPS beat(4)2
Avg EPS beat(4)-1.64%
Min EPS beat(4)-9.37%
Max EPS beat(4)3.93%
EPS beat(8)5
Avg EPS beat(8)2.02%
EPS beat(12)9
Avg EPS beat(12)4.08%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.57%
Min Revenue beat(2)-7.47%
Max Revenue beat(2)-1.68%
Revenue beat(4)2
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)1.8%
Revenue beat(8)4
Avg Revenue beat(8)-3.36%
Revenue beat(12)7
Avg Revenue beat(12)-1.35%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.17%
PT rev (3m)-7.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.97%
Valuation
Industry RankSector Rank
PE 10.62
Fwd PE 12.05
P/S 2.11
P/FCF 6.61
P/OCF 6.42
P/B 1.04
P/tB N/A
EV/EBITDA 7.5
EPS(TTM)0.13
EY9.42%
EPS(NY)0.11
Fwd EY8.3%
FCF(TTM)0.21
FCFY15.12%
OCF(TTM)0.21
OCFY15.57%
SpS0.65
BVpS1.33
TBVpS-0.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.41%
ROE 4.82%
ROCE 4.94%
ROIC 3.95%
ROICexc 5.79%
ROICexgc 80.17%
OM 19.38%
PM (TTM) 9.78%
GM 70.4%
FCFM 31.91%
ROA(3y)10.69%
ROA(5y)50.35%
ROE(3y)26.89%
ROE(5y)83.81%
ROIC(3y)14.05%
ROIC(5y)95.91%
ROICexc(3y)17.07%
ROICexc(5y)115.89%
ROICexgc(3y)197.06%
ROICexgc(5y)338.85%
ROCE(3y)17.53%
ROCE(5y)119.73%
ROICexcg growth 3Y-46.96%
ROICexcg growth 5YN/A
ROICexc growth 3Y3.36%
ROICexc growth 5YN/A
OM growth 3Y-13.39%
OM growth 5YN/A
PM growth 3Y-1.17%
PM growth 5YN/A
GM growth 3Y3%
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 4.71
Debt/EBITDA 4.71
Cap/Depr 7.71%
Cap/Sales 0.94%
Interest Coverage 1.38
Cash Conversion 103.97%
Profit Quality 326.14%
Current Ratio 11.84
Quick Ratio 10.32
Altman-Z 1.89
F-Score6
WACC8.22%
ROIC/WACC0.48
Cap/Depr(3y)5.45%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.49%
Cap/Sales(5y)0.29%
Profit Quality(3y)158.55%
Profit Quality(5y)178.05%
High Growth Momentum
Growth
EPS 1Y (TTM)-35%
EPS 3Y14.85%
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y-31.79%
EPS Next 2Y-15.39%
EPS Next 3Y-15.69%
EPS Next 5Y-2.8%
Revenue 1Y (TTM)-9.15%
Revenue growth 3Y17.53%
Revenue growth 5YN/A
Sales Q2Q%-3.62%
Revenue Next Year-10.02%
Revenue Next 2Y-6.26%
Revenue Next 3Y-3.4%
Revenue Next 5Y20.75%
EBIT growth 1Y-39.14%
EBIT growth 3Y1.79%
EBIT growth 5YN/A
EBIT Next Year-15.84%
EBIT Next 3Y-7.52%
EBIT Next 5Y-0.99%
FCF growth 1Y-44.41%
FCF growth 3Y10.47%
FCF growth 5YN/A
OCF growth 1Y-43.36%
OCF growth 3Y11.23%
OCF growth 5YN/A